Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 23;74(6):1089-1092.
doi: 10.1093/cid/ciab581.

Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State

Affiliations

Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State

Abbye E McEwen et al. Clin Infect Dis. .

Abstract

Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOCs) and had a median Ct of 20.2 (IQR, 17.1-23.3). When compared with 5174 contemporaneous samples sequenced in our laboratory, VOCs were significantly enriched among breakthrough infections (P < .05).

Keywords: SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Variants of concern are overrepresented in vaccine breakthrough SARS-CoV-2 genomes. A, Cumulative number of breakthrough cases and their Pangolin lineages. B, Proportions of lineages for UWVL sequences collected during the same time period. Relative risk of vaccine escape for each VOC (C) and spike amino acid change (D). Error bars represent 95% confidence intervals. *P < .05, **P < .01 (Fisher’s exact test). Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UWVL, University of Washington Virology Lab; VOC, variant of concern (total); VOC-R, variant of concern with reduced neutralization; VOC-WT, variant of concern without reduced neutralization; VOI, variant of interest.

References

    1. Funk CD, Laferrière C, Ardakani A. Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective. Viruses 2021; 13:418. - PMC - PubMed
    1. Hacisuleyman E, Hale C, Saito Y, et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 2021. Available at: http://dx.doi.org/10.1056/NEJMoa2105000. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. SARS-CoV-2 variant classifications and definitions. 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveill.... Accessed 19 May 2021.
    1. Garcia-Beltran WF, Lam EC, St Denis K, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 2021; 184:2523. - PMC - PubMed
    1. Nalla AK, Casto AM, Huang M-LW, et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol 2020; 58. Available at: http://dx.doi.org/10.1128/JCM.00557-20. - DOI - PMC - PubMed

Publication types

Substances